...
首页> 外文期刊>Journal of Clinical Microbiology >Mannosidase Production by Viridans Group Streptococci
【24h】

Mannosidase Production by Viridans Group Streptococci

机译:Viridans集团链球菌生产甘露糖苷酶

获取原文
           

摘要

The production of mannosidase activity by all currently recognized species of human viridans group streptococci was determined using an assay in which bacterial growth was dependent on the degradation of the high-mannose-type glycans of RNase B and subsequent utilization of released mannose. RNase B is an excellent substrate for the demonstration of mannosidase activity since it is a glycoprotein with a single glycosylation site which is occupied by high-mannose-type glycoforms containing five to nine mannose residues. Mannosidase activity was produced only by some members of the mitis group (Streptococcus mitis, Streptococcus oralis, Streptococcus gordonii, Streptococcus cristatus, Streptococcus infantis, Streptococcus parasanguinis, and Streptococcus pneumoniae) and Streptococcus intermedius of the anginosus group. None of the other species within the salivarius and mutans groups or Streptococcus peroris andStreptococcus sanguinis produced mannosidase activity. Using matrix-assisted laser desorption ionization time-of-flight mass spectrometry, it was demonstrated that the Man5 glycan alone was degraded while Man6 to Man9, which contain terminal α(1→2) mannose residues in addition to the α(1→3), α(1→6), and β(1→4) residues present in Man5, remained intact. Investigations on mannosidase production using synthetic (4-methylumbelliferone- orp-nitrophenol-linked) α- or β-mannosides as substrates indicated that there was no correlation between degradation of these substrates and degradation of the Man5 glycan of RNase B. No species degraded these α-linked mannosides, while degradation of the β-linked synthetic substrates was restricted to strains within the Streptococcus anginosus, S. gordonii, and S. intermedius species. The data generated using a native glycoprotein as the substrate demonstrate that mannosidase production within the viridans group streptococci is more widely distributed than had previously been considered.
机译:使用一种测定法来确定目前所有人类绿脓杆菌类链球菌物种中甘露糖苷酶活性的产生,其中细菌的生长取决于RNase B的高甘露糖型聚糖的降解以及随后利用释放的甘露糖。 RNase B是展示甘露糖苷酶活性的极佳底物,因为它是一种具有单个糖基化位点的糖蛋白,被含有5至9个甘露糖残基的高甘露糖型糖型所占据。甘露糖苷酶的活性仅由部分炎症组(链球菌,口头链球菌,戈登链球菌,creptus链球菌,婴儿链球菌,parasanguinis链球菌和肺炎链球菌)产生,并且链球菌群的中间链球菌。唾液和变异体组或 Perori链球菌 sanguinis链球菌中的其他物种均未产生甘露糖苷酶活性。使用基质辅助激光解吸电离飞行时间质谱,表明仅Man 5 聚糖被降解,而Man 6 至Man 9 < / sub>,其中除Man 5 ,保持不变。以合成的(4-甲基伞形酮或 p -硝基苯酚连接的)α-或β-甘露糖苷为底物生产甘露糖苷酶的研究表明,这些底物的降解与Man < RNase B的sub> 5 聚糖。没有物种降解这些α-连接的甘露糖苷,而β-连接的合成底物的降解仅限于链球菌Anginosus,S. gordonii S。 intermedius 物种。使用天然糖蛋白作为底物产生的数据表明,在viridans组链球菌内的甘露糖苷酶产生比以前考虑的分布更为广泛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号